| Primary |
| Migraine |
51.5% |
| Product Used For Unknown Indication |
24.5% |
| Drug Use For Unknown Indication |
4.8% |
| Headache |
4.5% |
| Cluster Headache |
1.6% |
| Prophylaxis Of Neural Tube Defect |
1.6% |
| Attention Deficit/hyperactivity Disorder |
1.3% |
| Sleep Disorder |
1.3% |
| Asthma |
1.1% |
| Migraine Prophylaxis |
1.1% |
| Sciatic Nerve Injury |
1.1% |
| Hypertension |
0.8% |
| Pain |
0.8% |
| Pain Management |
0.8% |
| Depression |
0.5% |
| Diabetes Mellitus |
0.5% |
| Migraine Headache |
0.5% |
| Migraine Without Aura |
0.5% |
| Myoclonic Epilepsy |
0.5% |
| Nausea |
0.5% |
|
| Product Quality Issue |
21.2% |
| Drug Ineffective |
16.8% |
| Loss Of Consciousness |
5.8% |
| Renal Aplasia |
5.8% |
| Product Substitution Issue |
5.1% |
| Renal Infarct |
5.1% |
| Vomiting |
5.1% |
| Drug Interaction |
4.4% |
| Pharyngeal Oedema |
4.4% |
| Nausea |
3.6% |
| Paraesthesia |
2.9% |
| Therapeutic Response Unexpected With Drug Substitution |
2.9% |
| Chest Discomfort |
2.2% |
| Chorioretinopathy |
2.2% |
| Flushing |
2.2% |
| Hypersensitivity |
2.2% |
| Syncope |
2.2% |
| Therapeutic Response Decreased |
2.2% |
| Throat Tightness |
2.2% |
| Apnoea |
1.5% |
|
| Secondary |
| Product Used For Unknown Indication |
44.9% |
| Migraine |
27.9% |
| Intentional Drug Misuse |
5.5% |
| Attention Deficit/hyperactivity Disorder |
2.7% |
| Completed Suicide |
2.7% |
| Hyperemesis Gravidarum |
2.7% |
| Suicide Attempt |
2.5% |
| Foetal Exposure During Pregnancy |
2.1% |
| Chronic Paroxysmal Hemicrania |
1.4% |
| Headache |
1.4% |
| Pain |
0.9% |
| Asthma |
0.7% |
| Bipolar Disorder |
0.7% |
| Pain Management |
0.7% |
| Pregnancy |
0.7% |
| Vitamin Supplementation |
0.7% |
| Ankylosing Spondylitis |
0.5% |
| Anxiety |
0.5% |
| Diabetes Mellitus |
0.5% |
| Drug Dependence |
0.5% |
|
| Completed Suicide |
14.5% |
| Toxicity To Various Agents |
10.1% |
| Product Quality Issue |
8.7% |
| Withdrawal Syndrome |
8.7% |
| Atrioventricular Block |
5.8% |
| Hypoglycaemia |
4.3% |
| Intestinal Ischaemia |
4.3% |
| Myalgia |
4.3% |
| Poisoning |
4.3% |
| Premature Delivery |
4.3% |
| Respiratory Arrest |
4.3% |
| Cardiac Arrest |
2.9% |
| Gastric Haemorrhage |
2.9% |
| Headache |
2.9% |
| Migraine |
2.9% |
| Overdose |
2.9% |
| Product Substitution Issue |
2.9% |
| Serotonin Syndrome |
2.9% |
| Tendonitis |
2.9% |
| Therapeutic Response Decreased |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.1% |
| Migraine |
14.4% |
| Pain |
5.3% |
| Drug Use For Unknown Indication |
4.7% |
| Headache |
4.1% |
| Depression |
3.2% |
| Rheumatoid Arthritis |
2.9% |
| Multiple Sclerosis |
2.8% |
| Crohn's Disease |
2.3% |
| Contraception |
2.2% |
| Anxiety |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Hypertension |
1.8% |
| Premenstrual Syndrome |
1.5% |
| Insomnia |
1.4% |
| Asthma |
1.1% |
| Sleep Disorder |
1.1% |
| Acne |
1.0% |
| Nausea |
1.0% |
| Acute Myeloid Leukaemia |
1.0% |
|
| Pulmonary Embolism |
13.4% |
| Drug Ineffective |
6.9% |
| Vomiting |
6.9% |
| Migraine |
6.0% |
| Deep Vein Thrombosis |
5.6% |
| Dysphemia |
5.6% |
| Weight Decreased |
5.6% |
| Stress |
5.1% |
| Affect Lability |
4.2% |
| Cognitive Disorder |
4.2% |
| Somnambulism |
4.2% |
| Urinary Tract Infection |
4.2% |
| Anxiety |
3.7% |
| Headache |
3.7% |
| Hypersensitivity |
3.7% |
| Injury |
3.7% |
| Nausea |
3.7% |
| Cholelithiasis |
3.2% |
| Oedema Peripheral |
3.2% |
| Pain |
3.2% |
|
| Interacting |
| Migraine |
60.0% |
| Back Pain |
20.0% |
| Product Used For Unknown Indication |
20.0% |
|
| Drug Interaction |
71.4% |
| Vomiting |
28.6% |
|
